|
CNKSR3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.0865310307604E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.93730032016504E-10 |
| Normal-vs-Stage2 |
1.740520E-03 |
| Normal-vs-Stage3 |
2.004300E-02 |
| Normal-vs-Stage4 |
8.048400E-02 |
| Stage1-vs-Stage2 |
9.385600E-01 |
| Stage1-vs-Stage3 |
9.245800E-02 |
| Stage1-vs-Stage4 |
2.124400E-03 |
| Stage2-vs-Stage3 |
2.004000E-01 |
| Stage2-vs-Stage4 |
4.230300E-02 |
| Stage3-vs-Stage4 |
3.979200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.84008405471559E-13 |
| Normal-vs-AfricanAmerican |
3.02019999998127E-06 |
| Normal-vs-Asian |
9.791000E-01 |
| Caucasian-vs-AfricanAmerican |
1.939010E-01 |
| Caucasian-vs-Asian |
5.542000E-02 |
| AfricanAmerican-vs-Asian |
8.137600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.93445301180873E-13 |
| Normal-vs-Female |
3.54380000000543E-06 |
| Male-vs-Female |
2.154600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.098800E-03 |
| Normal-vs-Extreme_Weight |
1.53869999963696E-07 |
| Normal-vs-Obese |
1.80239999592047E-08 |
| Normal-vs-Extreme_Obese |
3.342300E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.157600E-02 |
| Normal_Weight-vs-Obese |
2.026200E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.957400E-01 |
| Extreme_Weight-vs-Obese |
6.658000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.172400E-01 |
| Obese-vs-Extreme_Obese |
6.260200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.400500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.1477041539365E-11 |
| Normal-vs-Age(61-80Yrs) |
2.06289996196318E-09 |
| Normal-vs-Age(81-100Yrs) |
6.049800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.403600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.668200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.346400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.046000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.731610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.073800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.445650E-02 |
| Normal-VS-KIRP CIMP |
5.599600E-01 |
| Normal-VS-Unclassified PRCC |
3.019500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.40799652124247E-11 |
| Type1 PRCC-VS-KIRP CIMP |
1.575020E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.742800E-03 |
| Type2 PRCC-VS-KIRP CIMP |
4.431600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.295800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.868300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.337030E-03 |
| Normal-vs-N1 |
4.797800E-03 |
| Normal-vs-N2 |
7.797200E-01 |
| N0-vs-N1 |
6.346800E-01 |
| N0-vs-N2 |
3.562000E-01 |
| N1-vs-N2 |
2.594600E-01 |
|
|
